004720.KS
PharmGen Science, Inc.

Healthcare · Drug Manufacturers - General · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value

85.40M USD

Market Cap

48.74M USD

Margin of Safety

42.9%

Intrinsic / Market Ratio

1.75×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

74.34M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

90.92M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

90.92M USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

85.40M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

85.40M USD

from the sum above

Market Cap

48.74M USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

1.75×

the ratio the screener ranks by; Margin of Safety +42.9% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 74.34M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)61.77M USD
+②Net Cash Today12.57M USD
+③Growth Value0 USD
=Value74.34M USD

EPV of the Operations (NOPAT over WACC)

61.77M USD

Net cash today

+12.57M USD

Growth Value

0 USD

Value

74.34M USD

①EPV (earnings power value)

61.77M USD

②Net Cash Today

12.57M USD

③Growth Value

0 USD

Market value

Market Cap48.74M USD

The price on the date above times the shares.

Value vs market

Margin of Safety+34.4%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 90.92M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.

The projection was not made (a profit at or below zero in the latest three years), so the value is the book value today, 90.92M USD, as the screener leaves it.

①Present Value of the 15 Years of FCFE

Not in the value

②Equity at Year 15, Today

Not in the value

Market value

Market Cap48.74M USD

The price on the date above times the shares.

Value vs market

Margin of Safety+46.4%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 90.92M USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).

The projection was not made (a change in working capital above half the operating profit in the latest three years), so the value is the book value today, 90.92M USD, as the screener leaves it.

①Present Value of the 15 Years of FCFF

Not in the value

②Invested Capital at Year 15, Today

Not in the value

③Net Cash Today

Not in the value

Market value

Market Cap48.74M USD

The price on the date above times the shares.

Value vs market

Margin of Safety+46.4%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 7.35%
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.24×Market Risk Premium 6.00%= 5.93%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC 25.00% (default): the statements print a tax provision of -23.99M USD on a pretax income of -105.19M USD, which gives no rate between 0 and the profit before tax, so the 25% default stands for the tax the interest saves.

Interest Expense =EBIT -104.22M USD−Pretax Income -105.19M USD= 968.11K USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 968.11K USDTotal Debt 453.28K USD×(1 − Tax Rate for WACC 25.00%)= 160.18%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 453.28K USDMarket Cap + Total Debt 48.74M USD + 453.28K USD= 0.92%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 99.08%×Cost of Equity 5.93%+Debt Weight 0.92%×Cost of Debt 160.18%= 7.35%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 119.59M USD − Total Liabilities 28.67M USD = Book Value Today 90.92M USD

Total Debt 453.28K USD − Cash and Short-Term Investments 13.02M USD = Net Debt Today -12.57M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 122.0%at most 5%does not pass21,912,592 / 17,960,559
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets71.0%at least -10.0%passes(3.70M USD − -81.20M USD) ÷ 119.59M USD
Price to bookMarket Cap ÷ Book Value Today0.54×at most 3×passes48.74M USD ÷ 90.92M USD
Operating marginOperating Income ÷ Revenue3.5%above 10.0%does not pass4.17M USD ÷ 120.48M USD
Revenue growthRevenue ÷ Revenue a Year Before − 13.1%above 10.0%does not pass120.48M USD / 116.85M USD
Net cash(Cash − Total Debt) ÷ Market Cap25.1%above -30%passes(12.67M USD − 453.28K USD) ÷ 48.74M USD
Operating efficiencyOperating Income ÷ Gross Profit5.4%above 25.0%does not pass4.17M USD ÷ 77.74M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

2852.85 KRW

Enterprise value

57.16B KRW

the provider's own figure

EV / EBITDA

4.00×

Price / book

—

the provider's book

Price / earnings

—

Return on equity

0.1%

the provider's figure, not this page's

Profit margin

0.1%

Revenue growth

0.9%

Analyst target, mean

—

Analysts

—

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2022202320242025
Income statement

Revenue

119.88M130.65M116.85M120.48M

Gross profit

64.58M76.67M73.70M77.74M

Operating income

5.94M7.15M7.26M4.17M

EBITDA

operating income before depreciation and amortisation

76.92M13.28M6.69M-101.05M

Pretax income

71.45M6.62M693.94K-105.19M

Net income

55.65M4.77M1.90M-81.20M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

56.61M1.55M2.10M-80.82M

R&D

2.29M4.01M3.00M3.23M
Balance sheet, year end

Total assets

252.10M267.91M247.93M136.04M

Total liabilities

87.59M85.41M77.78M34.19M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

164.52M182.51M170.16M101.85M

Total debt

31.37M29.74M26.60M4.18M

Cash and equivalents

15.37M28.91M25.87M15.23M

Net PP&E

fixed assets after depreciation

33.71M32.33M26.51M26.59M

Working capital

current assets less current liabilities

1.87M25.19M30.89M43.43M
Cash flow

Operating cash flow

-1.02M4.26M1.63M3.70M

Capital expenditure

paid out, so below zero

-9.50M-2.58M-1.90M-1.86M

Depreciation and amortisation

2.68M3.33M3.16M3.17M

Free cash flow

operating cash flow plus capital expenditure

-10.52M1.68M-272.36K1.85M